Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2007
10/18/2007US20070243243 Oral dosage forms including an antiplatelet agent and an acid inhibitor
10/18/2007US20070243242 Compositions for treating hearing loss and methods of use thereof
10/18/2007US20070243241 Silicone Vesicles Containing Actives
10/18/2007US20070243240 Transdermal therapeutic system
10/18/2007US20070243237 Antimicrobial thin film coating and method of forming the same
10/18/2007US20070243231 Use of Whey Permeate for the Treatment of Metabolic Syndrome
10/18/2007US20070243225 Drug depot implant designs and methods of implantation
10/18/2007US20070243222 Fungicidal formulation and method of use
10/18/2007US20070243218 Stabilized pentosan polysulfate (PPS) formulations and methods of analyzing them
10/18/2007US20070243217 Film-Shaped Medicament for Oral Administration Containing Estriol
10/18/2007US20070243216 Stable solutions of prostaglandin and uses of same
10/18/2007US20070243185 Suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin; containing polypeptide with an aggregation inhibitor selected from the group consisting of L-arginine and L-cysteine.
10/18/2007US20070243180 Composition Containing Reduced Coenzyme Q
10/18/2007US20070243141 Mucosal or Cutaneous Medicinal or Hygiene System
10/18/2007US20070243140 Pharmaceutical composition containing sympathomimetic amine salt and co-distillable additive
10/18/2007US20070243138 Hollow microspheres with controlled fragility for medical use
10/18/2007US20070243136 Methods and Compositions for Imaging
10/18/2007US20070243131 Biopolymer system for tissue sealing
10/18/2007US20070243130 Biopolymer system for tissue sealing
10/18/2007DE102006017698A1 Zweiteilige Kapsel aus Metall zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren Two-piece capsule made of metal for holding pharmaceutical preparations for powder inhalers
10/18/2007DE102006017595A1 Verfahren zum Herstellen eines biokompatiblen Gerüstes, insbesondere zur Herstellung eines Implantates A method for manufacturing a biocompatible scaffold, in particular for the production of an implant
10/18/2007DE102006017320A1 Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel Aerosol suspension formulations with TG 227 ea or TG 134 a as propellant
10/18/2007CA2853611A1 High delivery rates for lipid based drug formulations, and methods of treatment thereof
10/18/2007CA2660310A1 Compositions of less immunogenic and long-circulating protein-lipid complexes
10/18/2007CA2649025A1 Production method of liposome dispersion and production equipment thereof
10/18/2007CA2648742A1 Compositions including relatively water insoluble/unwettable drugs and methods for using same
10/18/2007CA2648725A1 Fast release paracetamol tablets
10/18/2007CA2648473A1 Impact of calcium phosphate complex on dental caries
10/18/2007CA2648460A1 Calcium phosphate complex and salts in oral delivery systems
10/18/2007CA2648313A1 Calcium phosphate complex in acid containing chewing gum
10/18/2007CA2647073A1 Drug microparticles
10/18/2007CA2646578A1 Novel formulations
10/18/2007CA2646255A1 High delivery rates for lipid based drug formulations, and methods of treatment thereof
10/18/2007CA2645547A1 Biguanide-containing liposomes
10/18/2007CA2642757A1 Solid dispersion of poorly soluble drugs in graft copolymers
10/17/2007EP1844798A1 Implantable putty material
10/17/2007EP1844789A1 Emulsified composition for dilution and cancer vaccine composition
10/17/2007EP1844784A1 A pharmaceutical composition for the treatment of pathologies caused by the general response of the immune system
10/17/2007EP1844777A1 Chronic, bolus administration of d-treo methylphenidate
10/17/2007EP1844773A1 Percutaneous absorption preparation
10/17/2007EP1844772A1 Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications
10/17/2007EP1844770A1 Tablets containing ornithine hydrochloride
10/17/2007EP1844765A1 Contraception and hormone replacement therapy comprising a combination of estrogene with cholesterol and progesterone
10/17/2007EP1844764A2 Compound for use as a laxative
10/17/2007EP1844763A1 Percutaneously absorbable preparation, percutaneously absorbable preparation holding sheet, and percutaneously absorbable preparation holding equipment
10/17/2007EP1844201A2 Aqueous gel formulations containing immune response modifiers
10/17/2007EP1844142A2 Vectors and methods for genetic immunization
10/17/2007EP1844078A1 Pharmaceutical compositions with enhanced performance
10/17/2007EP1843783A2 Control of drug release by transient modification of local microenvironments
10/17/2007EP1843761A1 Extended release formulation of levetiracetam
10/17/2007EP1843758A1 Use of an active ingredient combination that contains hydroxystilbene for preventing and/or treating diseases
10/17/2007EP1843756A2 Formulations for production of capsule shells and capsules
10/17/2007EP1843755A2 Gastric retention and controlled release delivery system
10/17/2007EP1843754A1 New pharmaceutical composition containing candesartan cilexetil as lipophilic crystalline substance
10/17/2007EP1843753A2 Compositions for freeze-drying proteins
10/17/2007EP1843751A1 Pharmaceutical lipid compositions
10/17/2007EP1843750A1 Nebulizer formulation
10/17/2007EP1843749A1 Controlled release compositions for interferon based on pegt/pbt block copolymers
10/17/2007EP1843748A1 Solubilizate of a water-soluble organic acid and method for producing the same
10/17/2007EP1843747A2 Method for reducing the level of peroxides in bopcompatible polymer preparations
10/17/2007EP1843746A1 Somatostatin analogue formulations
10/17/2007EP1843745A1 Dosage forms of active ingredients containing hydroxystilbene for treating menopausal complaints
10/17/2007EP1843744A2 Stable prostaglandin-containing compositions
10/17/2007EP1843743A1 Pharmaceutical formulation administratable orally in terms of a taste, consistency and a dosing
10/17/2007EP1843733A1 Zero cycle molding systems, methods and apparatuses for manufacturing dosage forms
10/17/2007EP1755623A4 Treatment of lung diseases and pre-lung disease conditions
10/17/2007EP1646393A4 A stable clozapine suspension formulation
10/17/2007EP1608349B1 Oral delivery system comprising an antibacterial and an anti-inflammatory agent
10/17/2007EP1482911B1 Water dispersible mixture comprising complex carbohydrates from aloe vera and polyvinylpyrrolidone
10/17/2007EP1417487B1 Epitope testing using hla
10/17/2007EP1416916B1 Chitin microparticles and their medical uses
10/17/2007EP1412424B1 Improvements in or relating to modified cellulose films
10/17/2007EP1390699B1 Metering method for particulate material
10/17/2007EP1315505B1 Pharmaceutical compositions for headache, migraine, nausea and emesis
10/17/2007EP1211951B1 Process for manufacturing a pharmaceutical chewing gum
10/17/2007EP1102758B1 Particle-forming compositions containing fused pyrrolocarbazoles
10/17/2007EP1093818B9 Powdery preparation for mucosal administration containing polymeric medicine
10/17/2007EP1075276B1 Adjuvant composition and methods for its use
10/17/2007CN200960296Y Black plaster quantitative coating machine
10/17/2007CN101056637A Pharmaceutical composition for transdermal administration of perospirone
10/17/2007CN101056636A Aqueous ophthalmic suspension of crystalline rebamipide
10/17/2007CN101056625A Flavored gelatin capsule and method of producing said capsule
10/17/2007CN101056624A Controlled release pharmaceutical compositions comprising a fumaric acid ester
10/17/2007CN101056623A Stabilized freeze-dried formulation for cephalosporin derivatives
10/17/2007CN101056622A A process for preparing formulations of lipophilic active substances by spray freeze drying
10/17/2007CN101056621A Treatment of androgen-deprivation induced osteoporosis
10/17/2007CN101056620A Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally
10/17/2007CN101056619A Pharmaceutical compositions comprising a camtothecin derivate
10/17/2007CN101056618A Ophthalmic compositions and methods for treating eyes
10/17/2007CN101056617A In-situ forming implant for animals
10/17/2007CN101056616A The injection of tacrolimus
10/17/2007CN101056615A Ophthalmic oil-in-water type emulsion with stable positive zeta potential
10/17/2007CN101056614A 眼用溶液 Ophthalmic Solution
10/17/2007CN101056613A Controlled and directed local delivery of anti-inflammatory compositions
10/17/2007CN101056611A Gilsonite derived pharmaceutical delivery compositions and methods : cosmetic and nail applications
10/17/2007CN101056545A Thermally stable, high tensile strength encapsulated actives
10/17/2007CN101054414A Method of extracting and preparing deer DGF
10/17/2007CN101054377A Total alkaloids extraction of corydalis, its preparation method, medicine composition containing the total alkaloids extraction and application thereof
10/17/2007CN101054346A Preparation method and use for a set of novel compound and composition thereof
10/17/2007CN101053810A Method for preparing high molecular micro nanometer capsule
1 ... 1352 1353 1354 1355 1356 1357 1358 1359 1360 1361 1362 1363 1364 1365 1366 1367 1368 1369 1370 1371 1372 ... 2991